AMPLY Discovery

AMPLY Discovery is a UK (Belfast, Northern Ireland) biotechnology company turning the roughly 98% of the genome largely ignored by drug developers — the "dark genome" — into a pipeline of first-in-class therapeutics. The company pairs six AI/computational discovery engines with two wet labs in a closed loop between silicon and bench to find novel antimicrobial and therapeutic candidates targeting drug-resistant pathogens and complex diseases. AMPLY is a Techstars portfolio company and has been backed by Innovate UK, Invest NI, QUBIS and other UK/NI innovation programmes. It is tracked in the API Evangelist network as a company profile; AMPLY Discovery publishes no public developer API, documentation, SDKs, or machine-readable API surface at this time.

AMPLY Discovery is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Drug Discovery, Artificial Intelligence, and Genomics.

AMPLY Discovery’s developer surface includes engineering blog and 3 more developer resources.

🌐 Visit website 📡 Source on GitHub

5.5/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-21 · rubric v0.12.0

0 APIs

Company Biotechnology Drug Discovery Artificial Intelligence Genomics Pharmaceuticals Therapeutics

Kin Score

Kin Score How this is scored →
scored 2026-08-21 · rubric v0.12.0

Composite quality — 5.5/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.5 / 20

Access Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Contract Governance 0.0 / 12

Discoverability 5.0 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/amply-discovery: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 3

The organization behind the API

Website

Website

Blog

Blog

LinkedIn

Other 1

Properties that don't map to a standard resource type

Email

Source (apis.yml)

aid: amply-discovery
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/amply-discovery.png
name: AMPLY Discovery
description: AMPLY Discovery is a UK (Belfast, Northern Ireland) biotechnology company turning the roughly 98% of the genome
  largely ignored by drug developers — the "dark genome" — into a pipeline of first-in-class therapeutics. The company pairs
  six AI/computational discovery engines with two wet labs in a closed loop between silicon and bench to find novel antimicrobial
  and therapeutic candidates targeting drug-resistant pathogens and complex diseases. AMPLY is a Techstars portfolio company
  and has been backed by Innovate UK, Invest NI, QUBIS and other UK/NI innovation programmes. It is tracked in the API Evangelist
  network as a company profile; AMPLY Discovery publishes no public developer API, documentation, SDKs, or machine-readable
  API surface at this time.
url: https://raw.githubusercontent.com/api-evangelist/amply-discovery/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- techstars
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biotechnology
- Drug Discovery
- Artificial Intelligence
- Genomics
- Pharmaceuticals
- Therapeutics
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://amplydiscovery.com/
- type: Blog
  url: https://amplydiscovery.com/category/news/
- type: LinkedIn
  url: https://www.linkedin.com/company/amply-discovery
- type: Email
  url: mailto:contact@amplydiscovery.com
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/amply-discovery"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/amply-discovery/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/amply-discovery/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.